Earnings call briefThird-quarter 2026
CVS Health plans to separate into two independent publicly traded companies
CVS Health said it expects at least $8.65 in adjusted EPS in 2027, reflecting approximately 13% growth off an adjusted 2026 baseline.
GetSignal CVS Health CVS
CVS Health said on its third-quarter call that it plans to separate into two independent publicly traded companies, with completion expected in the first half of 2028, subject to customary conditions.
Chief Financial Officer Brian O. Newman said the company expects to resume its share repurchase program in the fourth quarter. Newman said the 2027 outlook assumes only an offset of dilution from share repurchases.
Quotes from the call
“Pulling it all together, and reflecting the strong performance we saw in the third quarter we now expect to deliver at least $8.65 in adjusted EPS in 2027, reflecting approximately 13% growth off an adjusted 2026 baseline.”
Key facts from the call
- Expected separation completion
- First half of 2028, subject to customary conditions
- Expected 2027 adjusted EPS
- At least $8.65, approximately 13% growth off an adjusted 2026 baseline
- Expected share repurchase program
- Resumption in the fourth quarter
Source: CVS Health's third-quarter 2026 earnings call, November 4, 2026.
Written by GetSignal with AI from the company's earnings call.
Not investment advice.
More earnings call briefs
- CVS Health raises 2026 cash flow outlook to at least $11.5 billion
CVS CVS Health Q2 2026 call
- Constellation Energy expects nuclear uprate costs of about $4.3 billion
CEG Constellation Energy Q3 2026 call
- Howard Hughes Holdings says its insurance ambition is a return on equity in excess of 20%
HHH Howard Hughes Holdings Q3 2026 call
- Brookfield Asset Management now sees 2026 earnings modestly below early view
BAM Brookfield Asset Management Q3 2026 call
- Enbridge says it expects 2026 results at the midpoint of its guidance range
ENB Enbridge Q3 2026 call
